JMP Securities Starts Abivax (ABVX) at Market Outperform

December 4, 2024 3:20 AM EST Send to a Friend
JMP Securities analyst Jason Butler initiates coverage on Abivax (NASDAQ: ABVX) with a Market Outperform rating and a price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login